AWK vs DRMAW
American Water Works (AWK) versus Dermata Therapeutics Inc. Warrant (DRMAW) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
DRMAW does not have a complete income-statement cache yet.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. DRMAW currently screens at market cap $0.
Not investment advice. Open the AWK and DRMAW stock pages for the full models.
Not investment advice.